These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8185007

  • 21. Vitamin E in tardive dyskinesia.
    Schneiderhan ME.
    Ann Pharmacother; 1993 Mar; 27(3):311-3. PubMed ID: 8453169
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.
    Richardson MA, Bevans ML, Read LL, Chao HM, Clelland JD, Suckow RF, Maher TJ, Citrome L.
    Am J Psychiatry; 2003 Jun; 160(6):1117-24. PubMed ID: 12777270
    [Abstract] [Full Text] [Related]

  • 23. Long-term treatment effects of vitamin E for tardive dyskinesia.
    Adler LA, Edson R, Lavori P, Peselow E, Duncan E, Rosenthal M, Rotrosen J.
    Biol Psychiatry; 1998 Jun 15; 43(12):868-72. PubMed ID: 9627740
    [Abstract] [Full Text] [Related]

  • 24. Severe tardive dyskinesia in affective disorders: treatment with vitamin E and C.
    Michael N, Sourgens H, Arolt V, Erfurth A.
    Neuropsychobiology; 2002 Jun 15; 46 Suppl 1():28-30. PubMed ID: 12571430
    [Abstract] [Full Text] [Related]

  • 25. Effects of intravenous metoclopramide in 81 patients with tardive dyskinesia.
    Doongaji DR, Jeste DV, Jape NM, Sheth AS, Apte JS, Vahia VN, Desai AB, Parikh MD, Rathi LG, Ghandi MH, Parikh RM, Thatte S, Bharadwaj J.
    J Clin Psychopharmacol; 1982 Dec 15; 2(6):376-9. PubMed ID: 7174860
    [Abstract] [Full Text] [Related]

  • 26. Oxidative mechanisms and tardive dyskinesia.
    Lohr JB, Kuczenski R, Niculescu AB.
    CNS Drugs; 2003 Dec 15; 17(1):47-62. PubMed ID: 12467492
    [Abstract] [Full Text] [Related]

  • 27. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG, Shin BS, Lee YC, Park SW, Kim YH.
    Psychiatry Clin Neurosci; 2007 Oct 15; 61(5):509-14. PubMed ID: 17875029
    [Abstract] [Full Text] [Related]

  • 28. Screening for tardive dyskinesia.
    Munetz MR, Schulz SC.
    J Clin Psychiatry; 1986 Feb 15; 47(2):75-7. PubMed ID: 2867994
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
    Lerner V, Kaptsan A, Miodownik C, Kotler M.
    Clin Neuropharmacol; 1999 Feb 15; 22(4):241-3. PubMed ID: 10442256
    [Abstract] [Full Text] [Related]

  • 31. Vitamin E in the treatment of tardive dyskinesia: a meta-analysis.
    Xu H, Qin H, Chen S, Guan M.
    Int Clin Psychopharmacol; 2022 Mar 01; 37(2):60-66. PubMed ID: 35045531
    [Abstract] [Full Text] [Related]

  • 32. Changes in tardive dyskinesia symptoms in elderly patients treated with ganglioside GM1 or placebo.
    Sommer BR, Cohen BM, Satlin A, Cole JO, Jandorf L, Dorsey F.
    J Geriatr Psychiatry Neurol; 1994 Mar 01; 7(4):234-7. PubMed ID: 7826493
    [Abstract] [Full Text] [Related]

  • 33. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A, Braus DF, Büchel C, Krumm B, Medori R, Gattaz WF.
    Psychiatr Prax; 2003 Sep 01; 30(6):333-7. PubMed ID: 12970819
    [Abstract] [Full Text] [Related]

  • 34. Failure of lithium treatment in established tardive dyskinesia.
    MacKay AV, Sheppard GP, Saha BK, Motley B, Johnson AL, Marsden CD.
    Psychol Med; 1980 Aug 01; 10(3):583-7. PubMed ID: 7003639
    [Abstract] [Full Text] [Related]

  • 35. Treatment of tardive dyskinesia with lecithin.
    Jackson IV, Nuttall EA, Ibe IO, Perez-Cruet J.
    Am J Psychiatry; 1979 Nov 01; 136(11):1458-60. PubMed ID: 40440
    [Abstract] [Full Text] [Related]

  • 36. Vitamin E treatment of tardive dyskinesia.
    Holmes VF, D'Alli R, Schweickert L, White R, Brown T, Doraiswamy M, Garcia M.
    Am J Psychiatry; 1993 Jun 01; 150(6):991; author reply 992-3. PubMed ID: 8494095
    [No Abstract] [Full Text] [Related]

  • 37. The effect of ceruletide on tardive dyskinesia: a double-blind placebo-controlled study.
    Matsunaga T, Ohyama S, Takehara S, Kabashima K, Moriyama S, Tsuzuki J, Ikeda H, Suematsu M, Akizuki K, Fujimoto K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 Jun 01; 12(4):533-9. PubMed ID: 3043555
    [Abstract] [Full Text] [Related]

  • 38. Buspirone in the treatment of tardive dyskinesia.
    Moss LE, Neppe VM, Drevets WC.
    J Clin Psychopharmacol; 1993 Jun 01; 13(3):204-9. PubMed ID: 8102622
    [Abstract] [Full Text] [Related]

  • 39. Treatment of tardive dyskinesia with propranolol.
    Schrodt GR, Wright JH, Simpson R, Moore DP, Chase S.
    J Clin Psychiatry; 1982 Aug 01; 43(8):328-31. PubMed ID: 6124534
    [Abstract] [Full Text] [Related]

  • 40. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F, Rascol O, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H, Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C.
    Mov Disord; 2013 Nov 01; 28(13):1838-46. PubMed ID: 23853029
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.